The Surprising Truth About Tablet Coating Equipment

luozhu

·November 21, 2025

·9 min read

Choosing the right tablet coating equipment is a key strategic decision for manufacturers. The global market's projected 5-7% annual growth underscores the importance of this investment. The best system aligns directly with specific goals for production volume, product variety, and quality control.

Continuous systems process tablets in a constant, non-stop flow to maximize output. In contrast, batch systems process a defined quantity at a time, offering greater flexibility for diverse product portfolios and smaller runs.

The Case for Batch Coating Systems

Batch systems offer distinct advantages for manufacturers who prioritize adaptability and precision over sheer volume. This type of tablet coating equipment excels in environments with diverse product lines and frequent changeovers.

The Advantage of Flexibility

Flexibility is the hallmark of batch coating systems. Manufacturers can easily switch between different products, tablet sizes, and batch volumes. Modern systems feature interchangeable pans and adjustable spray nozzles, which allow for quick adaptation. This modular design minimizes downtime between production runs.

For example, a contract manufacturer implemented a programmable batch system and reduced its setup time from four hours to just 30 minutes. This efficiency gain allowed the company to take on more projects, boosting its revenue by 20% in one year.

This adaptability makes batch systems an ideal choice for contract manufacturing organizations (CMOs) and companies producing a wide range of pharmaceuticals.

Superior Process Control for Small Runs

Batch systems provide exceptional control over the coating process, which is critical for high-value, low-volume products. Advanced control systems allow operators to fine-tune every aspect of the coating environment. This ensures a uniform, high-quality finish on every tablet. Key adjustable parameters include:

Pan speed and rotation for even coverage
Spray rate and nozzle position
Drying air temperature and volume
Exhaust air flow to maintain a stable environment

This level of precision minimizes material waste and guarantees that each small batch meets strict quality standards.

Lower Initial Capital Investment

For new companies or those expanding into new product areas, batch systems present a more accessible entry point. The initial capital investment for a batch coater is typically lower than for a continuous system. This cost-effectiveness allows businesses to allocate resources to other critical areas, such as research and development, while still acquiring high-quality production capabilities.

The Case for Continuous Coating Systems

When production demands shift from flexibility to high-volume output, continuous coating systems provide a powerful solution. This tablet coating equipment is engineered for large-scale manufacturing, where efficiency and consistency are the primary goals.

Achieving Maximum Throughput and Efficiency

Continuous coaters excel at maximizing production output. They process tablets in a constant, uninterrupted stream, eliminating the downtime between batches. This steady-state operation allows manufacturers to achieve significantly higher throughput rates compared to batch systems. The potential output varies based on the system and coating formulation.

System/Condition	Throughput Rate (kg/h)
High throughput continuous coater	1,000 to 2,000
O’Hara FCC 500 (nominal)	500 to 600
O’Hara FCC 500 with high-solids coating (35% solids)	~700
O’Hara continuous coater (3% target weight gain)	1,100 to 1,300

Modern systems also improve efficiency by incorporating energy-saving designs. Better insulation and optimized airflow reduce energy consumption, lowering operational costs and supporting sustainable manufacturing goals.

Unmatched Product Consistency

Continuous processing delivers exceptional product uniformity. Once the system reaches a steady state, every tablet experiences the exact same conditions. This results in a highly consistent coating weight and appearance from the first tablet to the last.

Studies confirm that continuous pharmaceutical coating processes lead to a "significant improvement of the uniformity of distribution of FC liquid."

Research highlights this advantage:

A Colorcon study found "superior coating weight and color uniformity compared to the traditional batch coater process."
Work in a Driaconti-T continuous coater showed that "coating uniformity was significantly improved over batch coaters."

This consistency is maintained through the integration of Process Analytical Technology (PAT). These tools monitor the process in real-time, allowing for immediate adjustments to ensure every tablet meets quality specifications.

Reduced Long-Term Labor Costs

While the initial investment may be higher, continuous systems can lead to significant long-term savings on labor. The automated nature of a continuous line reduces the need for constant operator intervention. A single, prolonged production run requires less manual oversight for startups, shutdowns, and quality checks compared to managing multiple individual batches. This operational model allows companies to reallocate skilled labor to more value-added tasks, optimizing workforce productivity and reducing the cost per unit over the equipment's lifespan.

Key Factors for Choosing Tablet Coating Equipment

Selecting the right system requires a careful analysis of several business and operational factors. The decision goes beyond technical specifications. It involves a strategic look at production goals, operational efficiency, and financial planning. A manufacturer must weigh these elements to find the equipment that best supports its long-term objectives.

Production Volume and Scale

Production volume is the most critical factor in this decision. A company's required output directly points toward either a batch or continuous system.

Batch Systems are ideal for low-to-medium volume production. They serve well in research and development (R&D), clinical trial manufacturing, and for producing niche or orphan drugs. Their design supports the production of specific, defined quantities.
Continuous Systems are built for high-volume, large-scale manufacturing. They are the best choice for blockbuster drugs or dedicated production lines that run for extended periods. Their purpose is to maximize throughput and produce millions of tablets consistently.

The choice depends entirely on the scale of the operation.

System Type	Ideal Production Scale	Typical Application
Batch System	Low to Medium Volume	R&D, Clinical Trials, CMOs
Continuous System	High to Very High Volume	Dedicated, Single-Product Lines

Product Changeover and Downtime

A manufacturer's product portfolio diversity heavily influences the importance of changeover time. Downtime is a direct cost, and minimizing it is essential for profitability. Batch systems are engineered for rapid product changeovers. The process typically involves cleaning the pan, swapping components if needed, and loading a new recipe. This agility allows companies, especially contract manufacturers, to handle multiple products in a single day.

Continuous systems present a different scenario. A product changeover is a significant undertaking. It requires a complete shutdown, extensive cleaning, and a lengthy startup process to re-establish a steady state. This results in considerable downtime and potential material loss.

For a business model built on producing many different products, the frequent and lengthy downtime of a continuous system would eliminate any efficiency gains. Agility, in this case, is more valuable than maximum throughput.

Therefore, companies with a diverse and frequently changing product list find batch systems more operationally and financially viable.

Capital vs. Operational Costs

The financial evaluation involves balancing the initial purchase price with long-term running costs. This comparison of Capital Expenditure (CapEx) versus Operational Expenditure (OpEx) is fundamental to choosing the right tablet coating equipment.

Capital Expenditure (CapEx): Batch systems have a significantly lower initial investment. Their simpler design and smaller footprint make them more accessible for startups, smaller companies, or those expanding their capabilities on a limited budget. Continuous systems demand a much higher upfront capital investment due to their size, complexity, and integrated control technologies.

Operational Expenditure (OpEx): The long-term cost profile reverses.

Continuous Systems: These systems offer a lower cost per tablet in high-volume settings. Automation reduces labor requirements, steady-state operation optimizes energy use, and process consistency minimizes material waste.
Batch Systems: These systems can have higher operational costs per unit. Each batch requires operator involvement for loading, unloading, and monitoring. Startups and shutdowns for multiple small batches can also consume more energy and labor relative to the output.

A manufacturer must decide whether to invest less upfront with potentially higher running costs (batch) or invest more initially to achieve lower long-term per-unit costs (continuous).

Batch-to-Batch Variability

Ensuring consistency from one production run to the next is a primary concern in pharmaceutical manufacturing. Batch-to-batch variability refers to the potential for slight differences between separate, discrete batches of tablets. This is a critical consideration for batch systems, as each run is an independent event with its own setup and processing cycle.

The goal is to produce a uniform product every time. Regulatory bodies set strict standards for this. While manufacturers often track Relative Standard Deviation (RSD), the current harmonized USP <905> standard focuses on a different metric.

The key quality measure is now the Acceptance Value (AV). This value, which accounts for the mean's deviation from the label claim and the standard deviation, must be no more than 15.0%. This provides a clear, harmonized target for product uniformity.

Achieving this level of consistency in a batch process requires advanced technology. Modern batch tablet coating equipment incorporates sophisticated tools to minimize variability. These technologies analyze materials before the process begins and monitor the coating in real-time.

Key technologies for analyzing raw materials include:

Dynamic Vapor Sorption (DVS) for detecting differences in particle size.
Inverse Gas Chromatography (iGC-SEA) for measuring surface area.

During the coating process, Process Analytical Technology (PAT) provides real-time data for immediate adjustments. These tools ensure every batch meets the same quality specifications.

Diffuse reflectance near-infrared (NIR) probes
Raman Spectroscopy
Terahertz pulsed imaging
Optical coherence tomography
Visible/ultraviolet digital image analysis
Multivariate Image Analysis (MIA)

In contrast, continuous systems inherently reduce batch-to-batch variability once they reach a steady state. The uninterrupted flow means that variations are smoothed out over the entire run. However, for manufacturers committed to a batch model, today's technology makes managing variability a highly achievable goal.

Making the Final Investment Decision

The final choice between a batch and a continuous system is a strategic one. It synthesizes all the factors of production volume, product mix, and financial planning. A manufacturer must align the equipment's capabilities with its core business objectives to ensure a successful, long-term investment.

When to Choose a Batch System

A company should select a batch system when its business model depends on agility and managing a diverse product portfolio. This equipment is the superior choice for specific operational scenarios.

🎯 A batch system is the right investment if the company:

Operates as a contract manufacturing organization (CMO) serving multiple clients.
Focuses on research and development (R&D) or clinical trial material production.
Manufactures a wide range of products with frequent changeovers.
Has a lower initial capital budget but can manage potentially higher per-unit operational costs.

When to Choose a Continuous System

A manufacturer should invest in a continuous system for high-volume, dedicated production lines where efficiency is paramount. This decision requires a thorough analysis of key performance indicators (KPIs) to justify the significant capital expenditure. Evaluating these metrics ensures the investment will deliver the expected returns.

KPI	Description
Overall Equipment Effectiveness (OEE)	Measures manufacturing productivity by combining availability, performance, and quality.
Production Yield	Quantifies the percentage of sellable product made from the total raw materials used.
Gross Profit Margin	Shows the percentage of revenue left after subtracting direct production costs (COGS).
Inventory Turnover Ratio	Indicates how many times inventory is sold and replaced over a specific period.

Tracking these KPIs provides critical business intelligence. They help identify waste to reduce costs and reveal the true profitability of a product line. This data-driven approach replaces guesswork with actionable information, enabling faster adaptation to market changes and creating a significant competitive advantage.

Ultimately, a continuous system is for businesses that prioritize maximum throughput, product consistency, and the lowest possible cost per tablet over the long term.

Choosing the right tablet coating equipment is a strategic business decision, not just a technical one. There is no single "best" system for every manufacturer. The ideal choice aligns with specific business objectives and future goals.

A company's final decision should be based on a thorough analysis of its production needs and long-term strategy.

Batch systems are the superior choice for flexibility, frequent product changeovers, and managing diverse portfolios, which is essential for trends like personalized medicine.
Continuous systems are built for high-volume, dedicated lines where efficiency, consistency, and low per-unit costs are the primary goals.

Looking ahead, manufacturers must also consider innovations like electrostatic coating and increased automation. These advancements will shape future competitiveness and influence long-term investment success.

FAQ

What is the main difference between batch and continuous coating?

Batch systems process a set quantity of tablets at one time. They are ideal for flexibility and varied products. Continuous systems process tablets in a constant flow. They excel at high-volume production of a single product, maximizing efficiency and output.

Can batch systems match the consistency of continuous systems?

Yes, modern batch systems can achieve high consistency. They use advanced Process Analytical Technology (PAT) to monitor and control the process in real-time. This technology minimizes variability between different batches, ensuring a uniform and high-quality product every time.

Which system is more cost-effective?

The cost-effectiveness depends on the production scale. Batch systems have a lower initial purchase price (CapEx). Continuous systems have higher upfront costs but offer a lower cost per tablet during large-scale production, reducing long-term operational expenses (OpEx).

How does a company's product pipeline affect the choice?

A company's product pipeline is a critical factor. A diverse pipeline with many new or varied products favors a flexible batch system. A company with a stable, high-volume blockbuster drug benefits more from an efficient, dedicated continuous system.

Tip: A manufacturer should always analyze its five-year production forecast. This helps align the equipment investment with long-term business growth and profitability goals.